Pediatric Antibiotic Stewardship

Antibiotics are the medications pediatricians prescribe most — and among the easiest to overuse. Antibiotic stewardship is the practice of prescribing them only when a child genuinely needs them, and, when they are needed, selecting the narrowest effective drug at the right dose, route, and duration.

Good stewardship protects individual children from avoidable side effects like C. difficile infection and allergic reactions, and it protects the community by slowing the spread of antibiotic resistance. Because most pediatric antibiotic use happens in the outpatient setting — and a substantial share of it is unnecessary — primary care practices, urgent care clinics, and emergency departments are where the greatest opportunity lies.

This page summarizes the AAP and Pediatric Infectious Diseases Society guidance on building and running antibiotic stewardship programs, adapted for Louisiana clinicians, with a link to the full policy statement.

Gerber JS, Jackson MA, Tamma PD, Zaoutis TE; AAP Committee on Infectious Diseases and Pediatric Infectious Diseases Society. Antibiotic Stewardship in Pediatrics. Pediatrics. 2021;147(1):e2020040295. Reaffirmed September 2025. Available at: https://publications.aap.org/pediatrics/article/147/1/e2020040295/33434/Antibiotic-Stewardship-in-Pediatrics

Join us for Pediatrics from the Parishes, August 13-16, 2026 at the Roosevelt Hotel in New Orleans, Louisiana.Pediatrics from the Parishes Conference logo

Pediatrics from the Parishes

A Conference Reimagined

August 13 - 16, 2026
The Roosevelt Hotel • New Orleans, LA

Antibiotics are the medications pediatricians reach for most often — and among the easiest to overuse. Stewardship means prescribing them only when a child truly needs them, and, when they are needed, choosing the narrowest effective drug at the right dose, route, and duration. The goal is simple: cure the infection while protecting the child, and the community, from avoidable harm.

Why stewardship matters for Louisiana children

Every antibiotic course carries risk alongside benefit. Beyond driving resistance, unnecessary antibiotics expose children to C. difficile infection, rashes, diarrhea, cytopenias, and anaphylaxis — and antibiotic reactions account for a large share of pediatric emergency visits for adverse drug events. The CDC estimates antibiotic-resistant infections cause roughly 3 million illnesses and 35,000 deaths in the United States each year. Growing evidence also links frequent early-life antibiotic exposure to disruption of a child's developing gut microbiome. Prescribing well is one of the highest-yield ways a pediatric practice can protect its patients.

The four questions of good prescribing

When an antibiotic is genuinely indicated, stewardship comes down to four decisions on every prescription:

  • Right drug — favor the narrowest-spectrum agent that reliably covers the likely pathogen. Broad-spectrum second-line drugs are often prescribed where a first-line narrow agent would work just as well, adding cost and adverse events without clinical benefit.
  • Right dose — weight-based and adequate to reach the site of infection.
  • Right route — oral therapy is effective for most common outpatient infections; reserve parenteral therapy for conditions where oral is known to fall short.
  • Right duration — for many common infections, shorter courses work. Reflexive 10- or 14-day courses are frequently longer than the evidence supports.

Where stewardship happens: inpatient vs. outpatient

Most pediatric antibiotic use — and most of the opportunity to improve it — happens in the outpatient setting, where roughly one in five sick-child visits ends in an antibiotic prescription and a large share of those are avoidable. The tools differ by setting:

SettingCore stewardship strategies
Inpatient / hospital Local treatment guidelines for common syndromes; prior approval for restricted agents; postprescription review with feedback at 48–72 hours; pharmacy-driven dose optimization and IV-to-oral conversion; a physician and pharmacist leader with pediatric ID expertise.
Outpatient / clinic, urgent care, ED Standardized prescribing guidance and clinical decision support; audit-and-feedback on prescribing rates; watchful waiting where appropriate; clinician communication training; caregiver education on the natural course of viral illness.

Outpatient priorities

Prescribe only when needed

Acute respiratory infections drive most pediatric antibiotic use, and a large fraction of those prescriptions are unnecessary. Antibiotics generally have no role in nonspecific upper respiratory infection, bronchiolitis, acute bronchitis, asthma exacerbations, or most conjunctivitis.

Diagnose before you treat

Tighten the diagnosis first: confirmatory pneumatic otoscopy for acute otitis media, a positive group A strep test before treating pharyngitis, and pyuria plus symptoms (with urinalysis and culture) before treating a urinary tract infection.

The opportunity: National estimates suggest outpatient pediatric antibiotic prescribing could be safely reduced by about 30% without worsening outcomes — a target well within reach of a standard-of-care primary care practice.

Building a program in your practice

An effective outpatient program does not require a hospital's infrastructure. It needs a committed clinician leader, a way to track and feed back prescribing data, and a shared set of local prescribing expectations. Emphasize the narrowest-spectrum drug for the shortest effective duration, close the loop on antibiotics started empirically when cultures return negative, and equip your team with brief, evidence-based scripts for the conversations parents worry about most. LA AAP can help Louisiana practices connect with stewardship resources and quality-improvement collaboratives.

Adapted by the Louisiana Chapter of the American Academy of Pediatrics from the AAP/Pediatric Infectious Diseases Society policy statement Antibiotic Stewardship in Pediatrics (Gerber JS, Jackson MA, Tamma PD, Zaoutis TE; AAP Committee on Infectious Diseases and Pediatric Infectious Diseases Society. Pediatrics. 2021;147(1):e2020040295; reaffirmed September 2025). Read the full policy statement at publications.aap.org. This summary does not indicate an exclusive course of treatment or serve as a standard of medical care; variations accounting for individual circumstances may be appropriate.